The World TPD & Induced Proximity Summit South Korea is the first and only Asian industry event dedicated exclusively to advancing targeted protein degradation (TPD) and induced proximity–based therapeutics.

As the global TPD field enters a pivotal era, with the first PROTAC approval on the horizon and multiple candidates progressing through clinical trials, South Korea has emerged as a major innovation hub, fuelled by rapid investment, strategic partnerships, and an expanding biotech ecosystem.

Designed as an end‑to‑end forum for degraders, molecular glues, and degrader antibody conjugates (DACs), the summit brings together international opinion leaders and Korean pioneers to address discovery challenges, translational strategy, clinical development, and emerging platform technologies. Deep‑dive sessions explore novel E3 ligases, AI‑enabled discovery workflows, proteomics‑driven target identification, PK/PD optimization, and case studies showcasing first‑in‑human PROTAC and DAC programs.

One Pass, Three Events: Part of the World Targeted Therapeutics Summit in South Korea organized by Hanson Wade, this is your opportunity to converge with peers working on antibody-drug conjugates (ADCs), Bispecifics, and T-cell engagers, who aim to turn South Korea into the next major global hub for biopharma innovation in targeted therapeutics.

To know more visit: https://ter.li/tslwfl